Us

Parexel sets its sights on stroke

Parexel sets its sights on stroke

By Phil Taylor

Parexel has made a bold foray into the troublesome arena of stroke drug development via an alliance with Safe Implementation of Treatments in Stroke (SITS) International, an international network of clinical sites geared up to recruit stroke patients.

First dissolution-focused CRO launched

First dissolution-focused CRO launched

By Emilie Reymond

Lab equipment specialist Sotax has announced the creation of a new contract research organisation (CRO) focused exclusively on dissolution testing services.

Balancing the clinical scales

Outsourcing-Pharma focus on: cutting the cost of clinical trials

Balancing the clinical scales

By Kirsty Barnes

As pharma companies flock towards Eastern Europe and India in a bid
to cut direct clinical trial costs, does outsourcing actually
translate into real world cost-savings?

Phase IIIB-IV research booming

Outsourcing-Pharma: Focus on Phase IIIB-IV research

Phase IIIB-IV research booming

By Kirsty Barnes

Phase IIIB-IV clinical research in the US is now booming, growing
20 per cent annually, compared with only 7 per cent for Phase
II-III research, driven by a surge in public drug safety concerns
and increased drug market competitiveness.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All